Senators Collins, Smith, King Introduce Bill to Combat Lyme and Other Tick-Borne Diseases

Washington, D.C. — U.S. Senators Susan Collins (R-ME) and Tina Smith (D-MN) today introduced legislation to reauthorize the Kay Hagan Tick Act, their landmark legislation to improve research, prevention, diagnostics, and treatment for tick-borne diseases, which became law in 2019. Senator Angus King (I-ME) joins them as an original co-sponsor. The Kay Hagan Tick Act unites the effort to confront the alarming public health threat posed by Lyme disease and other tick-borne diseases. Confirmed cases of Lyme disease reached a record number in Maine – 3,035 – last year. Senators Collins and Smith named their bill in honor of former Senator Kay Hagan (D-NC) who passed away on October 28^th, 2019, due to complications from the tick-borne disease known as the Powassan virus.

“Last year, Maine reported over 3,000 cases of Lyme disease—a record in our state. The reauthorization of our Tick Act is urgently needed to continue to support those who struggle with Lyme and other tick-borne illnesses and keep improving research, diagnostics, treatment, and prevention for these terrible diseases,” said Senator Collins. “Resources from the Tick Act have led to exciting developments such as the first-ever clinical trial for a Lyme disease vaccine for people, which is underway right now at the MaineHealth Institute for Research.”

“My home state of Minnesota is proud to have more than 10,000 lakes and thousands of rivers for us to enjoy, and we’re always especially eager to get outside after a long winter,” said Senator Smith. “Unfortunately, the number of Lyme disease cases in the state—and states across the country—is on the rise. This bill would empower regional centers to lead the response against these diseases and expanded the federal government’s role in researching, testing and treating these diseases. For the sake of Americans’ health and well-being, we need to keep moving this bill forward.”

“Our state has been battling diseases like Lyme for decades, so it is critical we continue to invest in our research and understanding of these vector-borne diseases to better protect Maine residents and visitors,” said Senator King. “The Kay Hagan Tick Act will further the prevention efforts that keep us safe by funding research, testing and diagnostics along with resources for improved data collection. I am proud to work on this critical bipartisan legislation that will help mitigate this long-term public health threat for the future safety and health of all Maine people.”

"Reauthorizing the Kay Hagan Tick Act will continue the nation's coordinated framework for tick-borne disease surveillance, diagnostics, and prevention”, said Griffin Dill, Director of the University of Maine Tick Lab. Continued support means earlier detection, targeted interventions, and fewer families facing the physical and financial burden of Lyme disease and other emerging infections. Through this investment, Congress can ensure a proactive approach to safeguarding our communities from increasing threats related to ticks."

“With an estimated 500,000 new cases of Lyme disease each year, it is critical that the United States is equipped to effectively prevent, detect, and respond to this growing public health threat,” said Bonnie Crater, co-founder and board member at Center for Lyme Action. “We applaud the foundation laid by the Kay Hagan Tick Act, which established the National Public Health Strategy to Prevent and Control Vector-Borne Diseases in Humans and we are committed to working with Congress and federal agencies to ensure this strategy is fully implemented and strengthened.  We commend Senator Collins, Senator King, and Senator Smith for their bipartisan leadership in advancing the reauthorization of this vital legislation to protect the health and safety of Americans nationwide.”

Using a three-pronged approach, the Kay Hagan Tick Reauthorization Act would:

1. Require the Department of Health and Human Services (HHS) to continue implementing and updating, as appropriate, its National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People.  This strategy has been integral in expanding research into tick-borne diseases, improving testing and diagnostics, and coordinating efforts across the federal government.

2. Reauthorize Regional Centers of Excellence in Vector-Borne Disease for five years. Funding for these centers, which was allotted in 2017, expires this year. These Centers have led the scientific response against tick-borne diseases, which now make up 75 percent of vector-borne diseases in the U.S.  There are four centers located at universities in California, Florida, Texas, and Wisconsin. 

3. Reauthorize CDC Grants to State Health Departments to improve data collection and analysis, support early detection and diagnosis, improve treatment, and raise awareness.  These awards would help states continue to build a public health infrastructure for Lyme and other vector-borne diseases and amplify their initiatives through public-private partnerships.   

In May, Senator Collins delivered the opening remarks at the Center for Lyme Action Congressional Series and spoke to the need for continued federal funding for tick-borne disease research. Click here to watch and here to download her remarks. Senator Collins has also urged leading health officials to continue to support the development of treatment for these illnesses, including the clinical trials currently ongoing in Maine for the first Lyme disease vaccine for people.

Senator King is a longtime advocate for the elimination of vector-borne diseases. His SMASH Act, bipartisan legislation to reauthorize critical public health tools that support states and localities in their mosquito surveillance and control efforts, especially those linked to mosquitos that carry the Zika virus, and improve the nation’s preparedness for Zika and other mosquito-borne threats like West Nile virus, chikungunya, and Eastern Equine Encephalitis (“triple-e”) virus was signed into law in 2019. A re-authorization of SMASH was introduced in 2023 and included in the Pandemic All-Hazards Preparedness Act Reauthorization.

###